(19)
(11) EP 4 256 046 A1

(12)

(43) Date of publication:
11.10.2023 Bulletin 2023/41

(21) Application number: 21901490.9

(22) Date of filing: 02.12.2021
(51) International Patent Classification (IPC): 
C12N 9/22(2006.01)
C12N 15/10(2006.01)
C12N 15/86(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 9/22; C12N 15/86; C07K 14/005; C12N 2750/14143; C12N 2750/14122; C12N 2310/20; C40B 40/08; C40B 40/02; C12N 15/1086; C12N 15/1089
(86) International application number:
PCT/US2021/061682
(87) International publication number:
WO 2022/120103 (09.06.2022 Gazette 2022/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 02.12.2020 US 202063120376 P

(71) Applicant: The Regents of The University of California
Oakland, CA 94607 (US)

(72) Inventors:
  • MALI, Prashant
    La Jolla, CA 92093 (US)
  • PALMER, Nathan
    La Jolla, CA 92093 (US)
  • KUMAR, Aditya
    La Jolla, CA 92093 (US)
  • SUHARDJO, Amanda
    La Jolla, CA 92093 (US)

(74) Representative: Gill Jennings & Every LLP 
The Broadgate Tower 20 Primrose Street
London EC2A 2ES
London EC2A 2ES (GB)

   


(54) ENGINEERING IMMUNE ORTHOGANOL AAV AND IMMUNE STEALTH CRISPR-CAS